Answers are grounded in this paper and cite their sources.
Rationale & Objective Infectious diseases have been associated with pediatric idiopathic nephrotic syndrome (NS). The impact of pandemic-related changes in infection exposure on NS epidemiology remains unclear. Study Design Retrospective Cohort Study. Setting & Participants Children aged 6 months–15 years from 11 hospitals in Japan using P-MICS data. Two periods were compared: pre-pandemic (Apr 2019–Mar 2020) and first pandemic year (Apr 2020–Mar 2021). Analytical Approach Event counts (new-onset Nephrotic syndrome (NS), relapse, respiratory tract infections (RTIs), acetaminophen prescriptions, COVID-19 diagnoses) were modeled using a negative binomial generalized linear mixed model with hospital-specific random intercepts. Sensitivity analyses used zero-inflated Poisson, Poisson mixed models, and quasi-Poisson. Results There were 218 new-onset NS cases (127 pre-pandemic, 91 during the pandemic). The pandemic period was associated with a decrease in incidence, and estimates were similar across distributional sensitivity analyses, whereas extended time-window analyses attenuated statistical significance. The relapse rate among 366 patients in remission was 0.094 per person-year before the pandemic and 0.056 per person-year during the pandemic; the period effect was not statistically significant. RTIs decreased by approximately half, and acetaminophen prescriptions declined. The number of COVID-19 diagnoses increased sharply. Limitations Observational design limits causal inference. Findings may not generalize beyond Japanese populations. Conclusions Reduced respiratory infection exposure during the pandemic may be associated with lower new-onset NS incidence. Preventive measures against respiratory infections may help reduce NS occurrence. Plain Language Summary Idiopathic nephrotic syndrome is a childhood kidney disease that causes edema and protein loss in the urine. Some relapses follow common colds. During the COVID-19 pandemic, masking and distancing reduced many respiratory infections, offering a chance to study how infection exposure relates to this disease. We used electronic medical records from pediatric hospitals in Japan to compare new diagnoses and relapses in the year before the pandemic with the first pandemic year, and we also tracked respiratory infection visits and use of fever medicine. New diagnoses were lower during the pandemic year, while relapses showed a smaller, uncertain change. Preventing respiratory infections may help reduce some cases and improve care for vulnerable children.
No takes yet. Share an insight, caveat, or question.
Asakawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: